Anti-Insulin (INS) Antibody ELISA Kit
Principle
This kit detects anti-insulin antibodies (IgG) in human serum samples based on the indirect method, with purified recombinant human insulin used as the coating antigen.
The testing process starts with adding the serum sample to reaction wells pre-coated with the antigen, followed by incubation. If insulin antibodies are present in the sample, they will specifically bind to the coated recombinant human insulin in the wells, forming stable antigen-antibody complexes.
After washing to remove unbound substances and avoid interference, enzyme conjugates are added to the wells. A second incubation step allows these enzyme conjugates to bind specifically to the existing antigen-antibody complexes. When TMB substrate solution is introduced, a color reaction occurs under the catalytic action of the enzyme in the complex. Finally, a microplate reader is used to measure the absorbance (A value), which enables the determination of the presence of anti-insulin antibodies in the sample.
Product Features
High sensitivity, specificity and stability
Product Specification
Principle | Enzyme linked immunosorbent assay |
Type | Indirect Method |
Certificate | NMPA |
Specimen | Human serum / plasma |
Specification | 48T / 96T |
Storage temperature | 2-8℃ |
Shelf life | 12 months |
Ordering Information
Product name |
Pack |
Specimen |
Anti-Insulin (INS) Antibody ELISA Kit |
48T / 96T |
Human serum / plasma |